Dermatofibroma pathophysiology: Difference between revisions

	Dermatofibroma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Dermatofibroma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Dermatofibroma pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Dermatofibroma pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Dermatofibroma pathophysiology
CDC on Dermatofibroma pathophysiology
Dermatofibroma pathophysiology in the news
Blogs on Dermatofibroma pathophysiology
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Dermatofibroma pathophysiology

Revision as of 14:44, 1 April 2013

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Some physicians and researchers believe dermatofibromas form as a reaction to previous injuries such as insect bites or thorn pricks.
Dermatofibromas are composed of disordered collagen laid down by fibroblasts.

Neoplasm	CD34	Stromelysin-3^[1]	Factor XIIIa^[2]
Dermatofibroma	+	+	+
Dermatofibrosarcoma protuberans	+	-	-

↑ Kim HJ, Lee JY, Kim SH; et al. (2007). "Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34". Br. J. Dermatol. 157 (2): 319–24. doi:10.1111/j.1365-2133.2007.08033.x. PMID 17596171. Unknown parameter |month= ignored (help)
↑ http://emedicine.medscape.com/article/1056742-overview

@@ Line 12: / Line 12: @@
 |-
 !  Neoplasm
-!  [[CD34]]<ref name="Bolognia" />
+!  [[CD34]]
 !  [[Stromelysin-3]]<ref>{{cite journal | pmid = 17596171 | doi=10.1111/j.1365-2133.2007.08033.x | volume=157 | issue=2 | title=Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34 | year=2007 | month=August | author=Kim HJ, Lee JY, Kim SH, ''et al.'' | journal=Br. J. Dermatol. | pages=319–24}}</ref>
 !  [[Factor XIIIa]]<ref>http://emedicine.medscape.com/article/1056742-overview</ref>